Prologue Journal

Biogen to Cut Roughly 11% of Workforce

• prologu5
• 07/25/202307/25/2023

Wall Street Journal

The biotech company cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products.

https://www.wsj.com/articles/biogen-to-cut-roughly-11-of-workforce-to-focus-on-big-return-drugs-145b3f23